Keywords: Chronic lung allograft dysfunction (CLAD), Bronchiolitis Obliterans Syndrome (BOS), Restrictive Allograft Syndrome (RAS), Lung allograft rejection, IL-17, Epithelial injury, Club cells, Club cell secretory protein, Biomarkers, Immune cells

Tereza Martinu, MD, MHSc

Clinician Scientist, Toronto Lung Transplant Program, UHN

CLAD team, in collaboration with the Juvet Laboratory

Scientist, Toronto General Hospital Research Institute

Associate Professor, University of Toronto: Temerty Faculty of Medicine, Institute of Medical Science, Immunology

Our group focuses on chronic lung allograft dysfunction (CLAD), the major cause of death beyond one year after lung transplantation. We apply single cell transcriptomics, proteomics, flow cytometry and microscopy imaging approaches to novel mouse models of CLAD, human lung-derived samples generously provided by our patients, as well as in-vitro cell culture systems. These strategies are used to study immune pathways, epithelial injury, and fibrosis in CLAD pathogenesis. Our goal is to elucidate mechanisms of CLAD and identify novel diagnostic and therapeutic targets for this condition.

Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

Click to enable/disable Google Analytics tracking code.
Click to enable/disable Google Fonts.
Click to enable/disable Google Maps.
Click to enable/disable video embeds.
Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.